{"id":"NCT00473382","sponsor":"Genentech, Inc.","briefTitle":"A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)","officialTitle":"A Phase III, Double-masked, Multicenter, Randomized, Sham Injection-controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06","primaryCompletion":"2011-01","completion":"2012-09","firstPosted":"2007-05-15","resultsPosted":"2013-01-17","lastUpdate":"2017-04-17"},"enrollment":382,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus","Macular Edema"],"interventions":[{"type":"DRUG","name":"Ranibizumab","otherNames":["Lucentis"]},{"type":"DRUG","name":"Sham injection","otherNames":[]}],"arms":[{"label":"Ranibizumab 0.3 mg","type":"EXPERIMENTAL"},{"label":"Ranibizumab 0.5 mg","type":"EXPERIMENTAL"},{"label":"Sham injection/ranibizumab 0.5 mg","type":"SHAM_COMPARATOR"}],"summary":"This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study of the efficacy and safety of ranibizumab injection in patients with clinically significant macular edema with center involvement (CSME-CI) secondary to diabetes mellitus (Type 1 or 2). This study is identical in design to study NCT00473330 (Protocol ID FVF4170g).\n\nThe open-label extension phase of the study was stopped after receiving FDA approval of the study drug (ranibizumab) for diabetic macular edema.","primaryOutcome":{"measure":"Percentage of Patients Who Gained â‰¥ 15 Letters in Their Best Corrected Visual Acuity (BCVA) Score From Baseline at Month 24","timeFrame":"Baseline to Month 24","effectByArm":[{"arm":"Ranibizumab 0.3 mg","deltaMin":33.6,"sd":null},{"arm":"Ranibizumab 0.5 mg","deltaMin":45.7,"sd":null},{"arm":"Sham Injection","deltaMin":12.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":26},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["39680390","37585454","31668888","31047503","31047350","30419298","29752001","27234930","26992841","26584450","26452713","26050541","25148789","24768239","23706949","22965590"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":54,"n":127},"commonTop":["Conjunctival haemorrhage (S)","Macular oedema (F)","Cataract (S)","Cataract (F)","Hypertension"]}}